I got my annual physical last spring. Blood pressure: normal. Cholesterol: fine. Fasting glucose: 96, which my doctor described as "nothing to worry about." I left with a clean bill of health, filed the results in a drawer, and moved on with my life. By every standard measure, I was healthy.
I was not.
What my doctor did not tell me — what he almost certainly did not know — is that a fasting glucose of 96 places me in a category that endocrinologists increasingly recognize as metabolically precarious. Not diabetic. Not even technically pre-diabetic, which begins at 100. But trending in a direction that, left unchecked, could arrive at insulin resistance, cardiovascular disease, or Type 2 diabetes within the next decade. And the standard annual physical I had just completed was specifically designed in a way that would miss every early warning sign of this trajectory.
My experience is not unusual. According to a landmark analysis published in Metabolic Syndrome and Related Disorders, only 12.2% of American adults meet the criteria for optimal metabolic health — defined as having ideal levels of blood glucose, triglycerides, HDL cholesterol, blood pressure, and waist circumference, without the use of medications (Araújo et al., 2019). That means 87.8% of American adults have at least one metabolic risk factor. And the majority of them, like me, have been told they are fine.
This is not a disease in the traditional sense. It is a slow, systemic deterioration of the body's ability to process energy — and it is happening on a scale that should terrify anyone paying attention.
What metabolic health actually means
To understand why metabolic health matters, you first need to understand what it is. And here is where the terminology gets confusing, because medicine has historically fragmented metabolic dysfunction into separate diseases — diabetes, heart disease, fatty liver disease, certain cancers — without adequately recognizing the common upstream driver that unites them.
Metabolic health, at its most fundamental, is the body's ability to efficiently convert food into energy and manage the byproducts of that conversion. This involves a cascade of interconnected processes: insulin signaling, glucose regulation, lipid metabolism, inflammation management, and mitochondrial function. When these systems work properly, the body maintains stable energy levels, appropriate body composition, normal blood pressure, and balanced blood lipids. When they break down, the consequences cascade through every organ system.
The concept that ties these processes together is insulin resistance — a condition in which cells become progressively less responsive to the hormone insulin, which is responsible for shuttling glucose from the bloodstream into cells for energy production. When cells resist insulin's signal, the pancreas compensates by producing more insulin — hyperinsulinemia — which temporarily maintains normal blood glucose levels but creates a host of downstream problems.
Elevated insulin promotes fat storage, particularly visceral fat around the organs. It drives inflammation. It increases blood pressure through sodium retention and vascular stiffening. It distorts lipid profiles, raising triglycerides and lowering protective HDL cholesterol. And it creates a self-reinforcing cycle: more visceral fat produces more inflammatory cytokines, which worsen insulin resistance, which drives more fat storage (Samuel & Shulman, 2016).
This is not speculative biochemistry. It is the mechanistic explanation for why conditions that appear clinically distinct — Type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, polycystic ovary syndrome, certain cancers, and possibly Alzheimer's disease (which some researchers have termed "Type 3 diabetes") — share common risk factors, common populations, and common metabolic underpinnings (de la Monte & Wands, 2008).
Why standard medicine misses it
The healthcare system is structured to diagnose diseases, not to detect the metabolic drift that precedes them. This is not a minor organizational distinction — it is a fundamental design flaw that allows the most consequential chronic health conditions to develop silently for years or decades before clinical detection.
Consider the diagnostic criteria for Type 2 diabetes: a fasting glucose above 126 mg/dL or a hemoglobin A1c above 6.5%. Pre-diabetes is diagnosed at a fasting glucose of 100-125 mg/dL or an A1c of 5.7-6.4%. These thresholds represent a late stage of metabolic dysfunction — by the time fasting glucose reaches 100, insulin resistance has typically been present for 10-15 years and the pancreas has already lost significant beta-cell function (Tabák et al., 2012).
The earlier and more sensitive marker — fasting insulin — is almost never measured in routine clinical practice. A study published in the Journal of the American College of Cardiology demonstrated that hyperinsulinemia (elevated fasting insulin) predicted cardiovascular events up to 20 years before they occurred, even in individuals with completely normal glucose levels (Després et al., 1996). Yet fasting insulin is not included in standard metabolic panels, is not part of routine health screening guidelines, and is not taught as a primary screening tool in most medical school curricula.
The reasons for this omission are partly historical and partly economic. The diagnostic framework for metabolic disease was developed in an era when Type 2 diabetes was relatively uncommon and was understood primarily through the lens of glucose metabolism. Insulin assays were expensive and technically challenging. And the pharmaceutical industry, which funds a significant portion of clinical research and continuing medical education, has had limited incentive to promote early detection of a condition whose primary treatment is lifestyle modification rather than medication.
The waist circumference problem
One of the simplest and most predictive measures of metabolic health — waist circumference — is measured by fewer than 20% of primary care physicians during routine visits, according to a survey published in Obesity Research & Clinical Practice (Smith & Haslam, 2007). This is remarkable given that waist circumference is a stronger predictor of cardiovascular risk and mortality than BMI, requires no laboratory testing, costs nothing, and takes approximately ten seconds to perform.
The explanation is partly cultural: discussing body composition with patients remains uncomfortable for many physicians, who receive minimal training in obesity medicine and often hold the same weight-related biases as the general population. A study in the Journal of General Internal Medicine found that physician anti-fat bias was associated with shorter visits, less health education, and poorer rapport with higher-weight patients (Phelan et al., 2015). The consequence is that one of the most accessible and informative metabolic health markers goes unmeasured in the majority of clinical encounters.
The dietary dimension
The rise of metabolic dysfunction in America tracks closely with a specific dietary shift: the dramatic increase in ultra-processed food consumption that began in the late 1970s and has accelerated ever since. Ultra-processed foods now constitute approximately 58% of total caloric intake for American adults and 67% for American children and adolescents (Martínez Steele et al., 2016).
Ultra-processed foods are not merely "unhealthy" in the way that candy or potato chips are traditionally understood. They are engineered food products — formulations of refined starches, sugars, seed oils, and chemical additives that are designed to maximize palatability, shelf stability, and consumption while minimizing production cost. Their impact on metabolic health operates through multiple mechanisms:
Glycemic load. Ultra-processed foods tend to produce rapid, large spikes in blood glucose — and corresponding insulin spikes — due to their refined carbohydrate content, lack of fiber, and rapid digestibility. Repeated glucose-insulin spikes create a metabolic environment that promotes insulin resistance over time. A study published in Cell Metabolism demonstrated that participants consuming an ultra-processed diet ate an average of 508 more calories per day than those consuming an equivalent minimally processed diet, without conscious awareness of the difference (Hall et al., 2019). The ultra-processed diet also produced measurably higher insulin secretion and more rapid weight gain over the two-week study period.
Seed oil consumption. The dramatic increase in consumption of refined seed oils — soybean, corn, canola, sunflower — represents one of the largest compositional changes in the American diet over the past century. Linoleic acid (omega-6) intake has increased from approximately 2% to 8% of total calories since 1909, a four-fold change that has shifted tissue fatty acid composition in measurable ways (Blasbalg et al., 2011). While the health implications remain debated, some researchers have argued that this shift has promoted chronic low-grade inflammation by increasing the substrate for pro-inflammatory eicosanoid synthesis (DiNicolantonio & O'Keefe, 2018).
Fructose metabolism. Added sugars — particularly high-fructose corn syrup, which became the dominant industrial sweetener in the 1980s — have unique metabolic effects that distinguish them from other caloric sources. Unlike glucose, which is metabolized by every cell in the body, fructose is metabolized almost exclusively by the liver. At high intakes, this hepatic fructose metabolism promotes de novo lipogenesis (fat creation in the liver), uric acid production, and the development of non-alcoholic fatty liver disease — a condition that was virtually unknown in children before 1980 and now affects an estimated 10% of American children (Lustig, 2010).
The exercise paradox
Physical activity is consistently identified as one of the most powerful interventions for metabolic health. A single bout of moderate exercise increases insulin sensitivity for 24-72 hours. Regular exercise reduces visceral fat, improves lipid profiles, lowers blood pressure, and enhances mitochondrial function independently of weight loss (Sylow et al., 2017).
Yet American adults are less physically active than at any point in recorded history. Data from the American Heart Association indicate that only 23% of adults meet the federal physical activity guidelines of 150 minutes of moderate aerobic activity per week plus two sessions of resistance training (Piercy et al., 2018). And accelerometer data — which is more accurate than self-report — suggests that the true figure may be even lower: a study using NHANES accelerometer data found that fewer than 5% of adults achieved 30 minutes of moderate activity per day (Troiano et al., 2008).
The decline in physical activity is not primarily a failure of individual willpower. It is a structural consequence of how American environments are designed. The built environment in most American communities requires automobile transportation, eliminates walking from daily routines, and provides few opportunities for incidental physical activity. Occupational physical activity has declined dramatically: in 1960, approximately 50% of American jobs required moderate physical activity. By 2010, that figure had dropped to 20% (Church et al., 2011). Americans are not lazy — they are living in environments that have engineered movement out of daily life.
The stress-metabolism connection
Chronic psychological stress is an underappreciated driver of metabolic dysfunction. The mechanism is well-characterized: stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which produces cortisol. Cortisol performs several metabolically relevant functions: it raises blood glucose (to fuel the fight-or-flight response), promotes visceral fat storage (as an energy reserve), increases appetite (particularly for calorie-dense foods), and suppresses insulin sensitivity (to maintain glucose availability for the brain and muscles).
In short bursts — an acute stressor followed by resolution — this response is adaptive and harmless. But chronic stress, which characterizes the daily experience of a significant proportion of the American population, sustains elevated cortisol levels in a way that progressively degrades metabolic health. A meta-analysis published in Obesity Reviews found that chronic stress exposure was independently associated with increased abdominal obesity, insulin resistance, and metabolic syndrome, after controlling for diet and physical activity (Wardle et al., 2011).
The populations most affected by chronic stress — those experiencing economic insecurity, racial discrimination, neighborhood disadvantage, caregiving burden, and occupational strain — are also the populations with the highest rates of metabolic disease. This is not coincidental. The social determinants of health operate, in significant part, through metabolic pathways. Poverty, racism, and structural inequality are not merely social phenomena — they are metabolic insults.
What reversal looks like
The most encouraging aspect of the metabolic health crisis is that metabolic dysfunction is, in its early and middle stages, substantially reversible. Unlike structural damage to organs — which may be permanent — the metabolic derangements of insulin resistance, dyslipidemia, and chronic inflammation respond robustly to behavioral intervention.
The Diabetes Prevention Program, one of the largest and most rigorous lifestyle intervention trials ever conducted, randomized 3,234 adults with pre-diabetes to either intensive lifestyle intervention (diet, exercise, and behavioral counseling), metformin, or placebo. The lifestyle intervention group reduced their risk of progressing to Type 2 diabetes by 58% — nearly twice the effect of metformin (31%) — with benefits persisting for at least 15 years after the trial ended (Knowler et al., 2002; Diabetes Prevention Program Research Group, 2015).
The lifestyle changes that drove these results were remarkably modest: 150 minutes per week of physical activity (primarily walking) and a 7% reduction in body weight. These are not extreme interventions. They are achievable changes that, when sustained, produce profound metabolic improvement.
More recent research has suggested that dietary quality may be even more important than caloric restriction. A trial published in JAMA compared low-fat and low-carbohydrate diets over 12 months and found that both groups improved metabolic markers significantly — but the strongest predictor of improvement was not the macronutrient ratio or the caloric deficit. It was the degree to which participants reduced ultra-processed food consumption and increased whole food intake (Gardner et al., 2018). The metabolic improvements were proportional to dietary quality, not dietary quantity.
The emerging science of metabolic monitoring
Continuous glucose monitors (CGMs) — small sensors worn on the skin that measure interstitial glucose every 1-5 minutes — have transformed diabetes management over the past decade. More recently, a growing number of metabolically healthy individuals have begun using CGMs for preventive health monitoring, creating a real-time window into their metabolic responses.
The data these devices generate is genuinely revelatory. A study published in Cell demonstrated that glycemic responses to identical foods vary enormously between individuals — differing by as much as five-fold — and are influenced by gut microbiome composition, sleep quality, meal timing, prior physical activity, and stress levels (Zeevi et al., 2015). Two people eating the same banana can have radically different glucose responses. This finding has profound implications for nutritional recommendations, which have historically assumed uniform metabolic responses to identical foods.
CGMs also reveal the metabolic consequences of behaviors that have no immediate symptoms. A night of poor sleep, a stressful meeting, a sedentary afternoon — all produce measurable glucose dysregulation that would be invisible without continuous monitoring. Whether this granular data is clinically useful for healthy individuals remains debated. But the ability to observe metabolic responses in real time has the potential to transform the abstract concept of "metabolic health" into something concrete, personal, and actionable.
What you can do now
The path to better metabolic health is neither exotic nor expensive. The evidence converges on a set of interventions that are accessible to most people, most of the time:
Reduce ultra-processed food consumption. This single change addresses multiple metabolic drivers simultaneously: glycemic load, inflammatory seed oil exposure, fructose metabolism, and caloric overconsumption. You do not need to eliminate processed foods entirely. Even modest reductions — replacing processed snacks with whole foods, cooking more meals from basic ingredients, reading ingredient lists — produce measurable metabolic improvement.
Walk after meals. A 10-15 minute walk after your largest meal reduces post-prandial glucose spikes by an average of 17-22%, improving glycemic control through the simplest possible intervention (Buffey et al., 2022). This is the lowest-effort, highest-impact metabolic habit available.
Prioritize resistance training. Skeletal muscle is the body's largest glucose sink — the primary tissue responsible for glucose disposal after meals. More muscle means more metabolic capacity. Even two 20-minute sessions of resistance training per week produce significant improvements in insulin sensitivity (Westcott, 2012).
Manage stress actively. Chronic stress is a metabolic toxin. Evidence-based stress reduction techniques — including meditation, deep breathing, time in nature, and adequate social connection — reduce cortisol levels and improve metabolic markers independently of diet and exercise changes.
Request better testing. Ask your physician for fasting insulin, hemoglobin A1c, a comprehensive lipid panel (including triglyceride-to-HDL ratio, which is one of the strongest correlates of insulin resistance), and hs-CRP. Track these longitudinally. A single snapshot is far less informative than a trend.
The metabolic health crisis is not inevitable. It is not genetic destiny. It is the predictable consequence of an environment that promotes processed food consumption, eliminates physical activity, maximizes stress, and monitors for disease only after it has arrived. The tools to reverse it are available now. What we need is the clarity to use them.
References
- Araújo, J., et al. (2019). Prevalence of optimal metabolic health in American adults. Metabolic Syndrome and Related Disorders, 17(1), 46–52.
- Blasbalg, T. L., et al. (2011). Changes in consumption of omega-3 and omega-6 fatty acids in the United States. American Journal of Clinical Nutrition, 93(5), 950–962.
- Buffey, A. J., et al. (2022). Acute effects of interrupting prolonged sitting. European Journal of Preventive Cardiology, 29(2), 333–342.
- Church, T. S., et al. (2011). Trends over 5 decades in US occupation-related physical activity. PLOS ONE, 6(5), e19657.
- de la Monte, S. M., & Wands, J. R. (2008). Alzheimer's disease is type 3 diabetes. Journal of Diabetes Science and Technology, 2(6), 1101–1113.
- Després, J. P., et al. (1996). Hyperinsulinemia as an independent risk factor for ischemic heart disease. NEJM, 334(15), 952–957.
- Diabetes Prevention Program Research Group. (2015). Long-term effects of lifestyle intervention or metformin. The Lancet Diabetes & Endocrinology, 3(11), 866–875.
- DiNicolantonio, J. J., & O'Keefe, J. H. (2018). Omega-6 vegetable oils as a driver of coronary heart disease. Open Heart, 5(2), e000898.
- Gardner, C. D., et al. (2018). Effect of low-fat vs low-carbohydrate diet on weight loss. JAMA, 319(7), 667–679.
- Hall, K. D., et al. (2019). Ultra-processed diets cause excess calorie intake and weight gain. Cell Metabolism, 30(1), 67–77.
- Knowler, W. C., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention. NEJM, 346(6), 393–403.
- Lustig, R. H. (2010). Fructose: Metabolic, hedonic, and societal parallels with ethanol. Journal of the American Dietetic Association, 110(9), 1307–1321.
- Martínez Steele, E., et al. (2016). Ultra-processed foods and added sugars in the US diet. BMJ Open, 6(3), e009892.
- Phelan, S. M., et al. (2015). Impact of weight bias and stigma on quality of care. Obesity Reviews, 16(4), 319–326.
- Piercy, K. L., et al. (2018). The physical activity guidelines for Americans. JAMA, 320(19), 2020–2028.
- Samuel, V. T., & Shulman, G. I. (2016). The pathogenesis of insulin resistance. Journal of Clinical Investigation, 126(1), 12–22.
- Smith, S. R., & Haslam, D. S. (2007). Abdominal obesity, waist circumference and cardiometabolic risk. European Heart Journal Supplements, 9(B), B30–B35.
- Sylow, L., et al. (2017). Exercise-stimulated glucose uptake — regulation and implications. Nature Reviews Endocrinology, 13(3), 133–148.
- Tabák, A. G., et al. (2012). Trajectories of glycaemia before diagnosis of type 2 diabetes. The Lancet, 379(9833), 2279–2290.
- Troiano, R. P., et al. (2008). Physical activity in the United States measured by accelerometer. Medicine & Science in Sports & Exercise, 40(1), 181–188.
- Wardle, J., et al. (2011). Stress and adiposity: A meta-analysis. Obesity Reviews, 12(5), e581–e606.
- Westcott, W. L. (2012). Resistance training is medicine. Current Sports Medicine Reports, 11(4), 209–216.
- Zeevi, D., et al. (2015). Personalized nutrition by prediction of glycemic responses. Cell, 163(5), 1079–1094.